Viewing Study NCT07226804


Ignite Creation Date: 2025-12-24 @ 7:55 PM
Ignite Modification Date: 2025-12-25 @ 5:30 PM
Study NCT ID: NCT07226804
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-10
First Post: 2025-11-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Overview

Official Title: Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules
Status: NOT_YET_RECRUITING
Status Verified Date: 2025-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To observe the outcomes of nsPFA therapy to treat benign thyroid nodules.
Detailed Description: Primary Objectives

• To evaluate the thyroid nodule volume changes over time in participants undergoing nsPFA as part of routine clinical care

Secondary Objectives

* To determine changes in health-related quality of life changes following ultrasound-guided nsPFA
* To evaluate the ultrasound features of thyroid nodules over time following ultrasound-guided nsPFA.
* To assess the incidence and nature of complications following ultrasound-guided nsPFA, categorized into Minor and Major complications.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
NCI-2025-08362 OTHER NCI-CTRP Clinical Registry View